Stock analysts at StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a report released on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Shares of Athersys stock opened at $0.01 on Monday. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99. The firm has a market capitalization of $833,206.50, a P/E ratio of -0.01 and a beta of -0.90.
About Athersys
Further Reading
- Five stocks we like better than Athersys
- Why Are Stock Sectors Important to Successful Investing?
- Is Spotify Stock Poised to Soar? Options Traders Think So
- What Makes a Stock a Good Dividend Stock?
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Short Selling: How to Short a Stock
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.